Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

ClinicalTrials.gov ID: NCT01889238

Public ClinicalTrials.gov record NCT01889238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2, SINGLE-ARM, OPEN-LABEL, MULTICENTER STUDY OF THE CLINICAL ACTIVITY AND SAFETY OF ENZALUTAMIDE IN PATIENTS WITH ADVANCED, ANDROGEN RECEPTOR-POSITIVE, TRIPLE-NEGATIVE BREAST CANCER

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if enzalutamide is safe and effective in the treatment of patients with advanced breast cancer that express the androgen receptor but do not express the estrogen or progesterone receptor and are not Her2 amplified.

Study identification

NCT ID
NCT01889238
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
118 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 12, 2013 (Actual)
Primary completion
Mar 1, 2015 (Actual)
Completion
Jan 10, 2024 (Actual)
Last update posted
Dec 13, 2024

2013 – 2024

United States locations

U.S. sites
95
U.S. states
16
U.S. cities
60
Facility City State ZIP Site status
Rocky Mountain Cancer Centers Colorado Springs Colorado 80907 —
Rocky Mountain Cancer Centers Lakewood Colorado 80228 —
Rocky Mountain Cancer Center Sky Ridge Lone Tree Colorado 80124 —
Rocky Mountain Cancer Centers Lone Tree Colorado 80124 —
Florida Cancer Specialists Altamonte Springs Florida 32701 —
Florida Cancer Specialists Bonita Springs Florida 34135 —
Florida Cancer Specialists Bradenton Florida 34209 —
Florida Cancer Specialists Brandon Florida 33511 —
Florida Cancer Specialists Cape Coral Florida 33914 —
Florida Cancer Specialists Clearwater Florida 33761 —
Florida Cancer Specialists Fort Myers Florida 33905 —
Florida Cancer Specialist South Division Fort Myers Florida 33908 —
Florida Cancer Specialists Fort Myers Florida 33908 —
Florida Cancer Specialists Fort Myers Florida 33916 —
Florida Cancer Specialists Gainesville Florida 32605 —
Florida Cancer Specialists Hudson Florida 34667 —
Florida Cancer Specialists Largo Florida 33770 —
Florida Cancer Specialists Naples Florida 34102 —
Florida Cancer Specialists New Port Richey Florida 34655 —
Florida Cancer Specialists Orange City Florida 32763 —
Florida Cancer Specialists Orlando Florida 32806 —
Florida Cancer Specialists Port Charlotte Florida 33980 —
Florida Cancer Specialists Sarasota Florida 34232 —
Florida Cancer Specialists Sarasota Florida 34236 —
Florida Cancer Specialists Spring Hill Florida 34608 —
Florida Cancer Specialists St. Petersburg Florida 33705 —
Florida Cancer Specialists Tampa Florida 33607 —
Florida Cancer Specialists Tavares Florida 32778 —
Florida Cancer Specialists Venice Florida 34285 —
Florida Cancer Specialists Venice Florida 34292 —
Northwestern Medical Faculty Foundation(NMFF)/ Women's Cancer Center Shared Laboratories Chicago Illinois 60611 —
Northwestern Medical Faculty Foundation Chicago Illinois 60611 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
The University of Chicago Medical Center, Investigational Drug Service Department of Pharmacy Chicago Illinois 60637 —
The University of Chicago Chicago Illinois 60637 —
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital New Lenox Illinois 60451 —
Indiana University Health Hospital Indianapolis Indiana 46202 —
Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 —
Investigational Drug Services Indianapolis Indiana 46202 —
Sidney and Lois Eskenazi Hospital Indianapolis Indiana 46202 —
Springmill Medical Clinic Indianapolis Indiana 46290 —
Oncology Hematology Care, Inc. Crestview Hills Kentucky 41017 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
The West Clinic, PC Corinth Mississippi 38834 —
The West Clinic, PC Southaven Mississippi 38671 —
Siteman Cancer Center City of Saint Peters Missouri 63376 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
Washington University Infusion Center Pharmacy St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Siteman Cancer Center-South County St Louis Missouri 63129 —
Siteman Cancer Center-West County St Louis Missouri 63141 —
Hematology Oncology Associates of Northern NJ Morristown New Jersey 07962 —
Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service New York New York 10065 —
Memorial Sloan-Kettering Cancer Center New York New York 10065 —
Cone Health Cancer Center Greensboro North Carolina 27403 —
Wesley Long Community Hospital Greensboro North Carolina 27403 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45211 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45219 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45230 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45236 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45242 —
Oncology Hematology Care, Inc. Fairfield Ohio 45014 —
Greenville Health System Greenville South Carolina 29605 —
Greenville Health System Seneca South Carolina 29672 —
Greenville Health System Spartanburg South Carolina 29307 —
Tennessee Oncology, PLLC Dickson Tennessee 37055 —
Tennessee Oncology, PLLC Franklin Tennessee 37067 —
Tennessee Oncology, PLLC Gallatin Tennessee 37066 —
Tennessee Oncology, PLLC Hermitage Tennessee 37076 —
Tennessee Oncology, PLLC Lebanon Tennessee 37087 —
Tennessee Oncology, PLLC Lebanon Tennessee 37090 —
The West Clinic, PC Memphis Tennessee 38104 —
The West Clinic, PC Memphis Tennessee 38120 —
Tennessee Oncology, PLLC Murfreesboro Tennessee 37129 —
Tennessee Oncology, PLLC Nashville Tennessee 37203 —
The Sarah Cannon Research Institute Nashville Tennessee 37203 —
Vanderbilt Breast Center at One Hundred Oaks Nashville Tennessee 37204 —
Vanderbilt Health Pharmacy One Hundred Oaks Nashville Tennessee 37204 —
Tennessee Oncology, PLLC Nashville Tennessee 37205 —
Tennessee Oncology, PLLC Nashville Tennessee 37207 —
Tennessee Oncology, PLLC Nashville Tennessee 37211 —
Henry-Joyce Cancer Clinic Nashville Tennessee 37232 —
Tennessee Oncology, PLLC Smyrna Tennessee 37167 —
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology - Memorial City Houston Texas 77024 —
Texas Oncology - Longview Cancer Center Longview Texas 75601 —
Texas Oncology-Tyler Tyler Texas 75702 —
Virginia Cancer Institute Mechanicsville Virginia 23116-1844 —
Virginia Cancer Institute Midlothian Virginia 23114 —
Virginia Oncology Associates Newport News Virginia 23606 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Cancer Institute Richmond Virginia 23230 —
Virginia Cancer Institute Richmond Virginia 23235-4730 —
Virginia Oncology Associates Virginia Beach Virginia 23456 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01889238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2024 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01889238 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →